Factors Affecting Weight Reduction after Intragastric Balloon Insertion: A Retrospective Study

Factors Affecting Weight Reduction after Intragastric Balloon Insertion: A Retrospective Study

Intragastric balloon (IGB) is a safe option for obesity management. However, studies determining the factors influencing the procedure's outcomes are scarce. Therefore, our goal was to determine the factors affecting weight reduction after IGB insertion. This retrospective study included 126 ob...

Full description

Saved in:
Bibliographic Details
Published in:Healthcare (Basel) Vol. 11; no. 4; p. 600
Main Authors: Bawahab, Mohammed A, Abbas, Khaled S, Maksoud, Walid M Abd El, Abdelgadir, Reem S, Altumairi, Khaled, Alqahtani, Awadh R, Alzahrani, Hassan A, Bhat, Muneer Jan
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 01-02-2023
MDPI
Subjects:
Body mass index
Cardiovascular disease
Care and treatment
excess weight loss
Gastrointestinal surgery
Health aspects
Hospitals
Implants, Artificial
intragastric balloon
Obesity
Pandemics
Patient outcomes
Prosthesis
Regression analysis
Statistical analysis
Surgery
Variables
Weight control
Weight loss
Saudi Arabia
United States > US
excess weight loss
intragastric balloon
obesity
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intragastric balloon (IGB) is a safe option for obesity management. However, studies determining the factors influencing the procedure's outcomes are scarce. Therefore, our goal was to determine the factors affecting weight reduction after IGB insertion. This retrospective study included 126 obese patients who underwent IGB treatment using the ORBERA Intragastric Balloon System. Patients' records were retrieved; and demographic data, initial body mass index (BMI), complications, compliance with both diet and exercise programs, and percentage of excess weight reduction were recorded. The study included 108 female (85.7%) and 18 male (14.3%) patients. The mean age was 31.7 ± 8.1 years. The percentage of excess weight loss (EWL) was 55.8 ± 35.7%. The mean weight loss was 13.01 ± 7.51 kg. A significant association was found between EWL and age, initial weight, initial body mass index, and the number of pregnancies. No major complications were observed. However, the balloon had to be removed early in two patients (1.59%) due to its rupture and in two other patients (1.59%) due to severe gastritis. IGB therapy is a safe and effective option for obesity management, associated with low rates of complications. The EWL after IGB insertion is significantly higher among older patients, those with a relatively low initial body mass index, those with a longer duration of IGB insertion, and female patients with less parity. Larger prospective studies are needed to support our results.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2227-9032
2227-9032
DOI:10.3390/healthcare11040600